Life Insurance
Consensus Index

AI Consensus Fit Review

North American Company for Life and Health Insurance Indexed Universal Life Insurance Fit Review for $2 Million or More in Coverage

North American Company for Life and Health Insurance is a good, but not conclusively best, fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

North American Company for Life and Health Insurance is a good, but not conclusively best, fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage. Six of the seven included AI platforms named the carrier during ranking discovery, and five of the six that returned a usable fit assessment rated it "good," with one "mixed" and one "uncertain." The strongest reason to consider it is a current IUL lineup that addresses both guaranteed death-benefit protection and accumulation-oriented designs, backed by A+ financial-strength ratings from AM Best, S&P, and Fitch. The main limitation is that no public source verifies jumbo-case underwriting performance, maximum face amounts, or policy-specific charges for this buyer profile.

Research Snapshot

FieldFinding
Platform mentions in ranking stage6 of 7 included platforms named the entity (anthropic, google, grok, kimi, openai, perplexity)
Share of included platform responses85.7% (6 of 7)
Average listed rank4.5
Best listed rank1 (perplexity)
Relevant product/model/planProtection Builder IUL 2 (protection-focused); Builder Plus IUL 4 (accumulation-oriented); Smart Builder IUL 3 referenced where its design better matches the accumulation objective
Overall use-case fitGood, with material verification required
Research date2026-09-21

Why North American Company for Life and Health Insurance Qualified for This Study

Questions This Section Answers

  • Why did North American Company for Life and Health Insurance qualify for a $2 million or more indexed universal life insurance study?
  • Which AI platforms named North American Company for Life and Health Insurance for large-face IUL coverage?

North American qualified because it was named by six of the seven included platforms during ranking discovery and because its current product materials directly address permanent protection and accumulation objectives relevant to a $2 million-plus indexed universal life buyer [1]. The carrier's ranking-stage average was 4.5, with a best listed rank of 1 and a final rank of 4 across the platforms that assessed fit.

Qualification was driven by three factors the platforms repeatedly cited: a documented IUL product family, strong financial-strength ratings, and a long operating history. North American has provided life insurance since 1886 and operates as part of Sammons Financial Group, a privately held employee-owned organization [3]. AM Best affirmed an A+ (Superior) Financial Strength Rating for North American in August 2025 [5], and Sammons reports S&P A+ and Fitch A+ Stable ratings for North American in 2026 [6]. North American's own materials state A+ ratings from AM Best, S&P Global, and Fitch [7].

Qualification does not equal verified superiority for this use case. The ranking-stage product list mixes several names — Accumulation IUL, Builder Plus IUL 2, Builder Plus IUL 4, Smart Builder IUL 3, Protection Builder IUL 2, and a "jumbo-focused" North American IUL — and the reviewed public sources most clearly support Protection Builder IUL 2 and Builder Plus IUL 4. The exact current availability of every supplied name is unclear.

The Product, Model, Plan, or Service Most Relevant to Indexed Universal Life Insurance for $2 Million or More in Coverage

Questions This Section Answers

  • Which North American Company for Life and Health Insurance IUL product should a buyer choose for $2 million or more of accumulation-focused coverage?
  • Is there a dedicated jumbo IUL product from North American Company for Life and Health Insurance for $2 million or more in coverage?

The most relevant products are Protection Builder IUL 2 for protection-focused designs and Builder Plus IUL 4 for accumulation-oriented designs, with Smart Builder IUL 3 potentially relevant where its design better matches the accumulation objective [11].

Protection Builder IUL 2 is positioned for guaranteed death-benefit protection and legacy and estate objectives. North American states that it can provide guaranteed death-benefit protection to age 120 with the Premium Guaranteed Rider, subject to terms, and the rider is available at issue only [11]. Builder Plus IUL 4 is positioned for death-benefit protection plus long-term cash-value accumulation, with indexed crediting and multiple death-benefit options [12]. Independent review coverage describes Builder Plus IUL 4 as North American's flagship accumulation product launched August 2024, designed for clients planning to max-fund and use the policy for tax-free retirement income through policy loans [13].

No dedicated jumbo product was confirmed. Independent review coverage states that no specific "Jumbo IUL" product is identified in available North American public materials, and that Builder Plus IUL 4 and Protection Builder IUL 2 are positioned as competitive products without explicit jumbo-market positioning language [15]. One platform's ranking-stage note referenced a "North American IUL (Jumbo-focused)," but the checked sources do not verify that label [16].

Minimum face amounts are well below the target. Builder Plus IUL 4 and Protection Builder IUL 2 start at $50,000 for ages up to 70, increasing to $100,000 for ages 71–75 [18]. One independent review reports coverage limits up to $3 million for those 50 or younger and up to $2 million for ages 51–60 [19], while another platform reports WriteAway accelerated underwriting up to $2 million for ages 18–60 [20]. These figures come from independent review sources and should be confirmed with the carrier.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about North American Company for Life and Health Insurance for $2 million or more in IUL coverage?
  • Is North American Company for Life and Health Insurance financially strong enough for a $2 million permanent IUL policy?

The platforms agreed on financial strength, product relevance, and the absence of verifiable large-face pricing. Agreement was strong but not unanimous, and platform agreement does not prove product quality.

On financial strength, the platforms consistently cited A+ ratings. AM Best affirmed A+ (Superior) in August 2025 [21], and Sammons reports S&P A+ and Fitch A+ Stable for North American in 2026 [22]. North American's own materials state A+ from AM Best, A+ (Strong) from S&P Global, and A+ (Stable) from Fitch [23]. One independent review notes the AM Best A+ is the second-highest rating out of 15 categories [27]. One platform also cited a low NAIC complaint index of 0.37 and $35B+ in assets [28].

On product relevance, the platforms agreed that North American markets indexed universal life products with indexed crediting strategies, cap and participation-rate mechanics, and a 0% floor before policy charges [31]. Independent review coverage describes 13 index selections including S&P 500, S&P MidCap 400, Russell 2000, EURO STOXX 50, and an exclusive Fidelity Multifactor Yield Index [34], with crediting methods including annual point-to-point, monthly point-to-point, and point-to-point with spread [35]. One platform reported four index choices with multiple crediting options [36].

On pricing, the platforms agreed that no public, buyer-specific premium quote exists for $2 million or more of coverage. Premiums depend on age, sex, health, tobacco status, underwriting class, face amount, death-benefit option, riders, funding pattern, state, and policy design [32].

Where the AI Platforms Disagreed or Were Uncertain

The platforms disagreed on overall fit rating and on large-face underwriting capability. Five of the six platforms that returned a usable fit assessment rated North American "good" (anthropic, deepseek, grok, openai), one rated it "mixed" (perplexity), and one rated it "uncertain" (kimi). This is a majority, not a consensus.

The sharpest disagreement concerned jumbo-case evidence. One platform stated that no independently verified evidence was found showing superior experience with $2 million-plus jumbo policies, and that public materials do not disclose jumbo underwriting limits or acceptance outcomes for high-income healthy applicants [37]. Another platform concluded that publicly verifiable evidence is insufficient to call North American a top-choice jumbo carrier without case-specific underwriting and pricing confirmation [40]. A third platform went further, rating fit "uncertain" because no verified source documents specific product names, charges, crediting structures, or competitive advantages against well-documented competitors [42].

Product-name conflicts remain unresolved. The ranking-stage list includes Accumulation IUL, Builder Plus IUL 2, Builder Plus IUL 4, Smart Builder IUL 3, Protection Builder IUL 2, and a jumbo-focused label. One platform reported that no searched source verified these product names, features, or existence in 2026 [42]. Another noted that the current public sources reviewed most clearly support Protection Builder IUL 2 and Builder Plus IUL 4, with the exact current availability of every supplied name unclear.

Litigation history is disputed and unresolved. A plaintiff lawyer advertisement mentions North American IUL fraud lawsuits alleging misrepresentation and unsuitable sales practices [43], and the general IUL industry has faced lawsuits over misleading illustrations and unsuitable recommendations [44]. No specific court verdicts, settlements, or regulatory enforcement actions against North American were confirmed in the available sources, and the nature, frequency, and outcome of alleged claims remain unclear.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What IUL features does North American Company for Life and Health Insurance offer for a $2 million accumulation-focused policy?
  • Does North American Company for Life and Health Insurance offer accelerated underwriting for a $2 million IUL application?

North American's use-case-relevant features center on crediting protection, policy-loan mechanics, premium-load structure, and accelerated underwriting. Most of these claims come from company-owned or independent review sources rather than regulatory filings.

Builder Plus IUL 4 includes a contractually guaranteed minimum S&P 500 participation rate of 100% at policy issue, which independent review coverage describes as non-reducible by the carrier regardless of options-cost changes [45]. The same product includes Variable Participating Policy Loans that allow borrowed funds to remain in index accounts and continue earning credits, plus current bonuses [45]. Builder Plus IUL includes an Account Interest Multiplier adding 10% guaranteed additional interest to the index account beginning in policy year 6, plus a guaranteed 1% interest bonus on the index account starting in policy year 11 [47].

Smart Builder IUL 3 offers a 0% premium load, meaning 100% of premiums less monthly deductions go to cash value, compared with an industry standard of 5–8% first-year premium loads [49]. One independent review states most IUL competitors charge 5–8% premium loads and that industry standard premium loads range 5–9% in the first year [50].

Accelerated underwriting is available. North American's WriteAway accelerated underwriting program is available on all products through the SimpleSubmit electronic application [51], and one platform reports WriteAway supports up to $2 million for ages 18–60 [53]. Builder Plus IUL 3 supports no lab tests or exams, online applications, and eSignature where permissible [51]. Whether WriteAway applies at the $2 million threshold for this buyer's age and health class is not confirmed in the reviewed sources.

Builder Plus IUL includes accelerated death benefit endorsements for critical, chronic, and terminal illness with no additional premium, and the maximum accelerated amount increased to $2 million as a lifetime maximum for all benefits [54]. For an ultra-high-net-worth buyer, that $2 million lifetime cap limits living-benefit flexibility.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does North American Company for Life and Health Insurance cost per month for $2 million or more of IUL coverage?
  • What fees and surrender charges apply to a North American Company for Life and Health Insurance IUL policy?

No public, buyer-specific premium quote was verifiable for $2 million or more of coverage, and pricing confidence across the platforms was low. Premiums depend on age, sex, health, tobacco status, underwriting class, face amount, death-benefit option, riders, funding pattern, state, and policy design [55].

Known cost categories include premiums required to keep the policy in force and satisfy any applicable no-lapse or premium-guarantee requirements; cost-of-insurance charges; premium loads; administrative or account charges; rider charges; surrender charges; and the economic effect of caps, spreads, or participation rates [55]. Policy loans carry potential loan interest and can reduce net death benefit or cash value [55].

Industry benchmarks provide context but not North American-specific pricing. One independent source states IUL industry standard costs range 2–4% annually including premium loads, administration fees, mortality charges, and surrender penalties [57]. The same source reports administration fees in the industry range of $50–$150 annually and policy expense charges in the industry range of $500–$2,000 in early years declining to $100–$300 by year 10, with North American-specific charges not disclosed [57]. One platform reported a benchmark of approximately $40,000–$80,000 annual premium for a healthy 45-year-old male seeking $5 million of IUL coverage, depending on funding design, explicitly noting these benchmarks are not North American-specific [58].

Contract terms carry material uncertainty. Surrender charges and loss of coverage or value may apply if the policy is surrendered or inadequately funded [55]. The policy and riders are state-specific, and features or issue ages may not be available in every state [59]. The Premium Guaranteed Rider is available at issue only [60]. One platform reported a No Lapse Guarantee on Builder IUL: if issued before age 55, coverage is guaranteed 20 years or to age 70, whichever is earlier; if issued after 55, guaranteed 15 years, with required premium payments. The specific surrender charge schedule and duration for Builder Plus IUL 4 and Protection Builder IUL 2 were not disclosed in public materials [61].

Best Suited For

Questions This Section Answers

  • Who is North American Company for Life and Health Insurance best suited for when buying $2 million or more of IUL coverage?
  • Is North American Company for Life and Health Insurance a good choice for legacy and estate planning with a large IUL policy?

North American is best suited for buyers prioritizing permanent death-benefit protection, legacy planning, or estate and business continuity, and for buyers who want an IUL with either a protection-oriented or accumulation-oriented design [62]. The carrier also fits cases where the agent can provide a detailed large-face-amount illustration and confirm underwriting availability.

Additional fit profiles cited across platforms include high-income buyers wanting permanent $2 million-plus IUL coverage for legacy, estate, or business planning; clients prioritizing long-term tax-deferred cash value accumulation for retirement income via policy loans; buyers seeking guaranteed minimum crediting protections such as the 100% S&P 500 participation floor on Builder Plus IUL 4; applicants in accelerated-underwriting-eligible health profiles needing efficient medical and financial vetting; and policyholders comfortable with variable participating policy loans that earn index credits while borrowed [64].

One platform also noted fit for buyers who prioritize carrier financial stability and jumbo policy experience over publicly verifiable product specifics, and for buyers working with advisors who can access proprietary illustration software and institutional pricing [67].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose North American Company for Life and Health Insurance for $2 million or more of IUL coverage?
  • Is North American Company for Life and Health Insurance a poor fit for buyers who need verified jumbo underwriting data?

North American is probably not best suited for buyers requiring independently verified evidence of superior jumbo-case underwriting speed or acceptance rates, or buyers seeking the highest available financial-strength ratings rather than a strong but lower-rated carrier [68]. The carrier's A+ ratings are strong but below the top ratings reported for some competing insurers.

Buyers unwilling to accept non-guaranteed crediting rates, adjustable policy charges, surrender exposure, and lapse risk should look elsewhere [70]. The same applies to buyers whose primary objective is a guaranteed lifetime death benefit without a specifically designed, funded, and maintained guarantee, and to buyers seeking the absolute lowest policy charges without regard to feature richness [71].

Other poor-fit profiles cited across platforms include buyers with significant health impairments or higher-risk occupations where a simplified-issue or table-shop carrier may be needed; buyers seeking published, transparent all-in IUL cost tables and guaranteed charge schedules before applying; self-directed buyers who require transparent, comparable product specifications before engaging an advisor; and buyers needing immediate cash value access in the first two to five years [72].

When Another Option May Be Better

Questions This Section Answers

  • When is another carrier a better choice than North American Company for Life and Health Insurance for $2 million or more of IUL coverage?
  • Which competing IUL carriers offer more documented large-face features than North American Company for Life and Health Insurance?

Another option may be better when maximum insurer-strength ranking is the buyer's primary criterion, when documented jumbo underwriting guidelines or demonstrable large-case placement experience is the main concern, or when a competing illustration provides materially lower guaranteed and current-assumption premiums, lower charges, or more favorable loan provisions for the same insured [75].

Competitor comparisons cited by the platforms include Pacific Life's return-of-premium rider offering 85% of premiums back on early surrender, multi-year and volatility-control indexed accounts, and a no-lapse guarantee to age 90 with a lifetime extension option [77]. John Hancock offers Protection versus Accumulation product tiers, an S&P 500 Fixed Index loan with a guaranteed bonus, a Nasdaq-100 linked account, published premium charges of 7% in year 1, 6% in years 2–10, and 2% in year 11 and later, administrative charges of $20 per month, and ExpressTrack accelerated underwriting with eligibility up to $5 million and potential one-day issuance [79]. One platform cited Protective Insurance at approximately $280 monthly for females and $325 monthly for males for standard face amounts [78].

Guaranteed universal life or participating whole life may be more efficient when the buyer values predictable lifetime death-benefit guarantees more than indexed cash-value upside [75]. Term plus GUL laddering may be more efficient for estate-liquidity certainty at lowest cost when the buyer is indifferent to cash value [81]. Buyers seeking coverage above $3 million without splitting policies across carriers may also need a different carrier, since one independent review reports coverage limits cap at $3 million for those 50 or younger [82].

Questions to Verify Before Buying

The platforms converged on a verification checklist rather than a purchase recommendation. Buyers should confirm the following before signing.

Confirm whether the requested $2 million-plus face amount is available in the buyer's state and at the proposed age and underwriting class, and whether the case qualifies for jumbo underwriting [83]. Confirm which product is being recommended — Protection Builder IUL 2, Builder Plus IUL 4, Smart Builder IUL 3, or another form — and why [83].

Request guaranteed values, current-assumption values, and reduced-crediting-rate values through life expectancy, plus guaranteed and current cost-of-insurance rates, premium loads, monthly charges, account charges, rider charges, and the full surrender schedule [86]. Confirm the exact premiums required to maintain the no-lapse guarantee or Premium Guaranteed Rider and what events can void that guarantee [83].

Confirm current caps, participation rates, spreads, floors, loan rates, loan options, and carrier rights to change them, and verify whether the 100% S&P 500 participation guarantee on Builder Plus IUL 4 is contractually non-reducible and survives policy in-force continuation [88]. Request a detailed explanation of Variable Participating Policy Loan mechanics, including how any interest bonus is calculated and whether it is guaranteed or subject to change [88].

Verify underwriting evidence requirements for a $2 million-plus application, including financial justification, medical records, paramedical testing, and foreign-travel review, and confirm whether WriteAway accelerated underwriting is available at the $2 million threshold or whether traditional medical underwriting is required [86]. Confirm issue-age limits and any occupational or aviation underwriting restrictions for $2 million-plus face amounts [90].

Verify whether North American has any pending or settled IUL-related litigation, regulatory enforcement actions, or consent orders, and request copies of any material compliance issues [91]. Confirm whether the Accelerated Death Benefit Endorsement, capped at $2 million lifetime, can be combined with multiple policies to increase living-benefit access [92].

Compare the proposal on guaranteed cost and value with at least two competing carriers at the same face amount and underwriting class, and request written confirmation that the policy will remain non-MEC when funded according to IRS guidelines and that tax-free loan treatment is maintained [86].

Final AI Consensus Verdict

North American Company for Life and Health Insurance is a good, but not conclusively best, fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage. Six of the seven included platforms named the carrier during ranking discovery, and five of the six that returned a usable fit assessment rated it "good," with one "mixed" and one "uncertain." The strongest reason to consider it is a current IUL lineup that addresses both guaranteed death-benefit protection and accumulation-oriented designs, backed by A+ financial-strength ratings from AM Best, S&P, and Fitch. The main limitation is that no public source verifies jumbo-case underwriting performance, maximum face amounts, or policy-specific charges for this buyer profile.

The verdict is conditional. North American should not be selected solely from marketing illustrations or product labels. Buyers should obtain a state-specific contract, jumbo-case underwriting confirmation, full guaranteed and non-guaranteed illustrations, and a comparative analysis of charges, guarantees, loans, and financial strength against at least two competing carriers. Platform agreement on financial strength and product relevance does not prove product quality or future policy performance.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-21. Seven AI platforms were configured for the study, and six returned a usable fit assessment for North American Company for Life and Health Insurance for Indexed Universal Life Insurance for $2 Million or More in Coverage. The ranking stage counted platforms that named the entity during discovery; the fit stage counted platforms that returned a usable assessment.

Platform-reported research dates differ from the authoritative run date. Five platforms reported 2026-09-21, and one platform (deepseek) reported 2026-06-11. Platform-reported dates are provenance metadata and do not independently prove freshness.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. Company-owned citations materially outnumber independent citations in the supplied catalog, so company claims are not described here as independently verified. No-search model claims require explicit verification before being described as current facts.

Methodology Limitations

Six of the seven included platforms returned a usable fit assessment, so the fit findings are not unanimous and should not be described as such. Platform mentions in the ranking stage count only platforms that named the entity during ranking discovery.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Company-owned citations materially outnumber independent citations, and company claims are not independently verified. Platform-reported research dates differ from the authoritative run date.

Conflicting product names, pricing, and capabilities were not resolved by guessing. The ranking-stage product list mixes several names, and the reviewed public sources most clearly support Protection Builder IUL 2 and Builder Plus IUL 4. The exact current availability of every supplied name is unclear.

No public premium schedule or policy-charge comparison was found for the target buyer profile. Non-guaranteed caps, participation rates, interest assumptions, and cost-of-insurance charges can materially affect long-term results. No independently verified evidence was found showing superior experience with $2 million-plus jumbo policies. The reviewed sources do not establish a maximum face amount, preferred underwriting outcome, or contract-specific premium for this buyer.

Sources

Company-Owned Sources

Independent Sources

  • Jumbo Policy IUL Explained — What High-Income Earners Need to Know in 2026: https://insurancebyheroes.com/jumbo-policy-iul-2/
  • North American Life Insurance Reviews: Pros, Cons & Coverage: https://insuranceguidances.com/north-american-life-insurance/
  • IUL Lawsuit Attorney: Cases, Settlements & Legal Options: https://legalclarity.org/iul-lawsuit-attorney-cases-settlements-legal-options/
  • AM Best Affirms Credit Ratings of Sammons Financial Group, Inc. and Its Subsidiaries: https://news.ambest.com/pr/PressContent.aspx?altsrc=2&refnum=36340
  • North American Life Insurance Review 2026 | A+ Rated: https://ogletreefinancial.com/blog/north-american-life-insurance-review/
  • What Are IUL Fees? Complete Cost Breakdown (2026: https://ogletreefinancial.com/blog/understanding-iul-fees/
  • AM Best ratings listing: https://www.ambest.com/ratings/
  • North American Company Life Insurance Review 2026 | IUL Specialists: https://www.insuranceandestates.com/north-american-company-review/
  • Best IUL Companies 2026 | Performance & Guarantees: https://www.insurancegeek.com/iul/best-iul-companies/
  • Best Indexed Universal Life Insurance (2026) | MoneyGeek: https://www.moneygeek.com/insurance/life/best/indexed-universal-life-insurance/
  • North American Life Insurance Review - RiskQuoter.com: https://www.riskquoter.com/company-reviews/north-american/
  • Wink Intel — life insurance industry sales and carrier coverage: https://www.winkintel.com/
  • Additional AI research evidence93 records
    1. AI research evidence record openai:c1
    2. AI research evidence record openai:c2
    3. AI research evidence record anthropic:c4
    4. AI research evidence record deepseek:nac-about
    5. AI research evidence record openai:c4
    6. AI research evidence record openai:c5
    7. AI research evidence record anthropic:c1
    8. AI research evidence record anthropic:c2
    9. AI research evidence record perplexity:c1
    10. AI research evidence record perplexity:c2
    11. AI research evidence record openai:c1
    12. AI research evidence record openai:c2
    13. AI research evidence record anthropic:c7
    14. AI research evidence record anthropic:c10
    15. AI research evidence record anthropic:c20
    16. AI research evidence record perplexity:c12
    17. AI research evidence record perplexity:c15
    18. AI research evidence record anthropic:c17
    19. AI research evidence record anthropic:c6
    20. AI research evidence record grok:8
    21. AI research evidence record openai:c4
    22. AI research evidence record openai:c5
    23. AI research evidence record anthropic:c1
    24. AI research evidence record anthropic:c2
    25. AI research evidence record perplexity:c1
    26. AI research evidence record perplexity:c2
    27. AI research evidence record anthropic:c3
    28. AI research evidence record grok:0
    29. AI research evidence record grok:15
    30. AI research evidence record grok:16
    31. AI research evidence record deepseek:nac-iul
    32. AI research evidence record openai:c3
    33. AI research evidence record perplexity:c12
    34. AI research evidence record anthropic:c15
    35. AI research evidence record anthropic:c16
    36. AI research evidence record perplexity:c4
    37. AI research evidence record openai:c1
    38. AI research evidence record openai:c2
    39. AI research evidence record openai:c6
    40. AI research evidence record perplexity:c12
    41. AI research evidence record perplexity:c15
    42. AI research evidence record kimi:c1
    43. AI research evidence record anthropic:c21
    44. AI research evidence record anthropic:c22
    45. AI research evidence record anthropic:c9
    46. AI research evidence record grok:5
    47. AI research evidence record anthropic:c12
    48. AI research evidence record perplexity:c12
    49. AI research evidence record anthropic:c10
    50. AI research evidence record anthropic:c11
    51. AI research evidence record anthropic:c13
    52. AI research evidence record anthropic:c14
    53. AI research evidence record grok:8
    54. AI research evidence record anthropic:c18
    55. AI research evidence record openai:c3
    56. AI research evidence record deepseek:nac-iul
    57. AI research evidence record anthropic:c19
    58. AI research evidence record kimi:c1
    59. AI research evidence record openai:c6
    60. AI research evidence record openai:c1
    61. AI research evidence record anthropic:c20
    62. AI research evidence record openai:c1
    63. AI research evidence record openai:c2
    64. AI research evidence record anthropic:c9
    65. AI research evidence record anthropic:c13
    66. AI research evidence record grok:8
    67. AI research evidence record kimi:c1
    68. AI research evidence record openai:c1
    69. AI research evidence record openai:c2
    70. AI research evidence record openai:c3
    71. AI research evidence record anthropic:c19
    72. AI research evidence record deepseek:nac-iul
    73. AI research evidence record kimi:c1
    74. AI research evidence record anthropic:c20
    75. AI research evidence record openai:c1
    76. AI research evidence record openai:c2
    77. AI research evidence record kimi:c3
    78. AI research evidence record kimi:c4
    79. AI research evidence record kimi:c2
    80. AI research evidence record kimi:c5
    81. AI research evidence record deepseek:nac-iul
    82. AI research evidence record anthropic:c6
    83. AI research evidence record openai:c1
    84. AI research evidence record perplexity:c12
    85. AI research evidence record openai:c2
    86. AI research evidence record openai:c3
    87. AI research evidence record anthropic:c19
    88. AI research evidence record anthropic:c9
    89. AI research evidence record grok:8
    90. AI research evidence record anthropic:c20
    91. AI research evidence record anthropic:c21
    92. AI research evidence record anthropic:c18
    93. AI research evidence record kimi:c1

Other Sources

  • Additional AI research evidence93 records
    1. AI research evidence record openai:c1
    2. AI research evidence record openai:c2
    3. AI research evidence record anthropic:c4
    4. AI research evidence record deepseek:nac-about
    5. AI research evidence record openai:c4
    6. AI research evidence record openai:c5
    7. AI research evidence record anthropic:c1
    8. AI research evidence record anthropic:c2
    9. AI research evidence record perplexity:c1
    10. AI research evidence record perplexity:c2
    11. AI research evidence record openai:c1
    12. AI research evidence record openai:c2
    13. AI research evidence record anthropic:c7
    14. AI research evidence record anthropic:c10
    15. AI research evidence record anthropic:c20
    16. AI research evidence record perplexity:c12
    17. AI research evidence record perplexity:c15
    18. AI research evidence record anthropic:c17
    19. AI research evidence record anthropic:c6
    20. AI research evidence record grok:8
    21. AI research evidence record openai:c4
    22. AI research evidence record openai:c5
    23. AI research evidence record anthropic:c1
    24. AI research evidence record anthropic:c2
    25. AI research evidence record perplexity:c1
    26. AI research evidence record perplexity:c2
    27. AI research evidence record anthropic:c3
    28. AI research evidence record grok:0
    29. AI research evidence record grok:15
    30. AI research evidence record grok:16
    31. AI research evidence record deepseek:nac-iul
    32. AI research evidence record openai:c3
    33. AI research evidence record perplexity:c12
    34. AI research evidence record anthropic:c15
    35. AI research evidence record anthropic:c16
    36. AI research evidence record perplexity:c4
    37. AI research evidence record openai:c1
    38. AI research evidence record openai:c2
    39. AI research evidence record openai:c6
    40. AI research evidence record perplexity:c12
    41. AI research evidence record perplexity:c15
    42. AI research evidence record kimi:c1
    43. AI research evidence record anthropic:c21
    44. AI research evidence record anthropic:c22
    45. AI research evidence record anthropic:c9
    46. AI research evidence record grok:5
    47. AI research evidence record anthropic:c12
    48. AI research evidence record perplexity:c12
    49. AI research evidence record anthropic:c10
    50. AI research evidence record anthropic:c11
    51. AI research evidence record anthropic:c13
    52. AI research evidence record anthropic:c14
    53. AI research evidence record grok:8
    54. AI research evidence record anthropic:c18
    55. AI research evidence record openai:c3
    56. AI research evidence record deepseek:nac-iul
    57. AI research evidence record anthropic:c19
    58. AI research evidence record kimi:c1
    59. AI research evidence record openai:c6
    60. AI research evidence record openai:c1
    61. AI research evidence record anthropic:c20
    62. AI research evidence record openai:c1
    63. AI research evidence record openai:c2
    64. AI research evidence record anthropic:c9
    65. AI research evidence record anthropic:c13
    66. AI research evidence record grok:8
    67. AI research evidence record kimi:c1
    68. AI research evidence record openai:c1
    69. AI research evidence record openai:c2
    70. AI research evidence record openai:c3
    71. AI research evidence record anthropic:c19
    72. AI research evidence record deepseek:nac-iul
    73. AI research evidence record kimi:c1
    74. AI research evidence record anthropic:c20
    75. AI research evidence record openai:c1
    76. AI research evidence record openai:c2
    77. AI research evidence record kimi:c3
    78. AI research evidence record kimi:c4
    79. AI research evidence record kimi:c2
    80. AI research evidence record kimi:c5
    81. AI research evidence record deepseek:nac-iul
    82. AI research evidence record anthropic:c6
    83. AI research evidence record openai:c1
    84. AI research evidence record perplexity:c12
    85. AI research evidence record openai:c2
    86. AI research evidence record openai:c3
    87. AI research evidence record anthropic:c19
    88. AI research evidence record anthropic:c9
    89. AI research evidence record grok:8
    90. AI research evidence record anthropic:c20
    91. AI research evidence record anthropic:c21
    92. AI research evidence record anthropic:c18
    93. AI research evidence record kimi:c1

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
34
Ranking mentions
6 of 7
Platform share
86%
Final consensus rank
#4

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

14 independent · 19 company-owned · 1 unclear

Evidence support

23 direct · 9 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

fb3aea847e7d478bf0d68693ad7acefa0b32ab1739b6428b624dff1c6d3f365f